SCHEMBL5282260

SCHEMBL5282260

O=C(O)CC(c1ccccc1)n1cnc2ccc(NC(=O)c3cncc(Br)c3)cc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
KDR P35968 1/20 0.47
NPC1 O15118 5/20 0.46
HTT P42858 5/20 0.46
MAPT P10636 5/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
RAB9A P51151 4/20 0.46
MAPK1 P28482 2/20 0.46
TSHR P16473 1/20 0.46
CASP3 P42574 5/20 0.44
ALDH1A1 P00352 4/20 0.43
ROCK2 O75116 1/20 0.43
GAA P10253 1/20 0.43
ALOX12 P18054 1/20 0.43
ROCK1 Q13464 1/20 0.43
USP2 O75604 1/20 0.43
HPGD P15428 1/20 0.43
TP53 P04637 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5300027 0.93 KMT2A (0.48) MEN1KMT2AKDRNPC1HTT
SCHEMBL2298655 0.89 RAB9A (0.48) NPC1HTTMAPTSMN1; SMN2RAB9A
SCHEMBL2297005 0.89 MAPT (0.49) MEN1KMT2ANPC1MAPTSMN1; SMN2
SCHEMBL2294478 0.88 NPC1 (0.48) MEN1KMT2ANPC1HTTMAPT
SCHEMBL2295492 0.87 RAB9A (0.51) MEN1KMT2ANPC1HTTMAPT
SCHEMBL2295384 0.86 KCNK3 (0.46) MEN1KMT2ANPC1HTTMAPT
SCHEMBL2299812 0.84 NPC1 (0.45) MEN1KMT2ANPC1MAPTSMN1; SMN2
SCHEMBL2299394 0.84 F2 (0.44) MEN1KMT2ANPC1MAPTSMN1; SMN2
SCHEMBL2292514 0.83 RAB9A (0.47) MEN1KMT2ANPC1MAPTSMN1; SMN2
SCHEMBL2298688 0.83 NPC1 (0.48) MEN1KMT2ANPC1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828144-A2 INTEGRIN ANTAGONISTS USEFUL AS ANTICANCER AGENTS OSI Pharmaceuticals, Inc. (US) 2007-09-05 EP claimed
WO-2006053342-A2 INTEGRIN ANTAGONISTS USEFUL AS ANTICANCER AGENTS OSI PHARMACEUTICALS, INC. (US) 2006-05-18 WO claimed